181 related articles for article (PubMed ID: 4976473)
1. Effect of nalidixic acid on deoxyribonucleic acid synthesis in bacteriophage SPO1-infected Bacillus subtilis.
Gage LP; Fujita DJ
J Bacteriol; 1969 Apr; 98(1):96-103. PubMed ID: 4976473
[TBL] [Abstract][Full Text] [Related]
2. Effect of nalidixic acid on PBS2 bacteriophage infection of Bacillus subtilis.
Price AR; Fogt SM
J Virol; 1973 Aug; 12(2):405-7. PubMed ID: 4201189
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleic acid synthesis in bacteriophage SPO1-infected Bacillus subtilis. I. Bacteriophage deoxyribonucleic acid synthesis and fate of host deoxyribonucleic acid in normal and polymerase-deficient strains.
Yehle CO; Ganesan AT
J Virol; 1972 Feb; 9(2):263-72. PubMed ID: 4622590
[TBL] [Abstract][Full Text] [Related]
4. Resistance of bacteriophage PBS2 infection to 6-(p-hydroxyphenylazo)-uracil, an inhibitor of Bacillus subtilis deoxyribonucleic acid synthesis.
Price AR; Fogt SM
J Virol; 1973 Feb; 11(2):338-40. PubMed ID: 4631841
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal action of nalidixic acid on Bacillus subtilis.
Cook TM; Brown KG; Boyle JV; Goss WA
J Bacteriol; 1966 Nov; 92(5):1510-4. PubMed ID: 4958883
[TBL] [Abstract][Full Text] [Related]
6. RNA synthesis during bacteriphage SPO1 development. II. Some modulations and prerequisites of the transcription program.
Gage LP; Geiduschek EP
Virology; 1971 Apr; 44(1):200-10. PubMed ID: 4999125
[No Abstract] [Full Text] [Related]
7. Effect of nalidixic acid on the growth of deoxyribonucleic acid bacteriophages.
Baird JP; Bourguignon GJ; Sternglanz R
J Virol; 1972 Jan; 9(1):17-21. PubMed ID: 4621668
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of erythromycin on bacteriophage SPO1 multiplication in sporulating cells of Bacillus subtilis 168.
Hirochika H
Mol Gen Genet; 1980; 179(3):581-8. PubMed ID: 6777627
[TBL] [Abstract][Full Text] [Related]
9. DNA gyrase inhibitors block development of Bacillus subtilis bacteriophage SP01.
Alonso JC; Sarachu AN; Grau O
J Virol; 1981 Sep; 39(3):855-60. PubMed ID: 6270354
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of 5-hydroxymethyluracil and its deoxynucleoside in noninfected and phage-infected Bacillus subtilis.
Nishihara M; Friedman N; Vasken Aposhian H
J Virol; 1969 Feb; 3(2):164-70. PubMed ID: 4975365
[TBL] [Abstract][Full Text] [Related]
11. DNA synthesis in toluene-treated bacteriophage-infected minicells or Bacillus subtilis.
Amann E; Reeve JN
Biochim Biophys Acta; 1978 Aug; 520(1):82-7. PubMed ID: 100140
[TBL] [Abstract][Full Text] [Related]
12. Eclipse of viral DNA infectivity in SPO1-infected Bacillus subtilis.
Levner MH
Virology; 1972 Oct; 50(1):267-72. PubMed ID: 4628252
[No Abstract] [Full Text] [Related]
13. Abortive infection of lysogenic Bacillus subtilis 168(SPO2) by bacteriophage phi 1.
Rettenmier CW; Hemphill HE
J Virol; 1974 Apr; 13(4):870-80. PubMed ID: 4206942
[TBL] [Abstract][Full Text] [Related]
14. The action of virginiamycin on nucleic acid and protein synthesis in Bacillus subtilis infected with bacteriophage 2C.
Cocito C
J Gen Microbiol; 1969 Aug; 57(2):195-206. PubMed ID: 4981917
[No Abstract] [Full Text] [Related]
15. Control of DNA synthesis in Bacillus subtilis by phage phi e.
Marcus M; Newlon MC
Virology; 1971 Apr; 44(1):83-93. PubMed ID: 4999126
[No Abstract] [Full Text] [Related]
16. Selective replication of bacteriophage phi29 deoxyribonucleic acid in 6-(p-hydroxyphenylazo)-uracil-treated Bacillus subtilis.
Schachtele CF; Reilly BE; De Sain CV; Whittington MO; Anderson DL
J Virol; 1973 Jan; 11(1):153-5. PubMed ID: 4630798
[TBL] [Abstract][Full Text] [Related]
17. Effect of antibiotics on certain aspects of bacteriophage SP-15 development in Bacillus subtilis W23.
Dosmar M; Markewych O; Witmer H
J Virol; 1977 Mar; 21(3):924-31. PubMed ID: 403301
[TBL] [Abstract][Full Text] [Related]
18. In situ lysis of phi29- and SPO1-infected Bacillus subtilis.
Hagen EW; Anderson DL
J Virol; 1975 Jan; 15(1):217-20. PubMed ID: 803567
[TBL] [Abstract][Full Text] [Related]
19. Replication of viral DNA in SPO1-infected Bacillus subtilis. I. Replicative intermediates.
Levner MH; Cozzarelli NR
Virology; 1972 May; 48(2):402-16. PubMed ID: 4623500
[No Abstract] [Full Text] [Related]
20. Bacillus subtilis DNA polymerase III is required for the replication of the virulent bacteriophage phi e.
Lavi U; Nattenberg A; Ronen A; Marcus M
J Virol; 1974 Dec; 14(6):1337-42. PubMed ID: 4214945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
